Clinical Evidence

CapsoCam Plus® has been proven to be a safe and effective diagnostic tool. Ongoing research and clinical evaluations continue to expand the range of clinical indications.

Clinical outcomes from international studies performed with the CapsoCam small bowel capsule. These studies were conducted outside the U.S. and any results have not been evaluated by the U.S. Food and Drug Administration (FDA).

CapsoCam SV-1 Versus PillCam SB3 in the Detection of Obscure Gastrointestinal Bleeding

Lilli L. Zwinger, M.D.*Christian Bojarski M.D. *, et al. J Clin Gastroenterology. 2019 ; Volume 53, Number 3.

World‘s largest series with CapsoCam®. Feasibility, completion and detection rate of the new generation of capsule endoscope with a 360° lateral panoramic view – A single center retrospective study.

Thomas Pachofszky M.D. -Dept. of Gastroenterology, Hepatology and Endoscopy Hospital, Rudolfstiftung,
Vienna, Austria Presented at UEGW 2019, Barcelona, Spain

Extensive small-bowel Crohn’s disease detected by newly introduced 360° panoramic viewing capsule endoscopy system

Tontini GE, et al. New VCE system identifies Crohn’s disease…Endoscopy 2014; 46:E353-E354

First clinical trial of a newly developed capsule endoscope with panoramic side view for small bowel: A pilot study

Friedrich K, Sieg A, et al. Journal of Gastroenterology and Hepatology 2013; (28): 1496-1501